TRIAL DETAIL
BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Ongoing, but not recruiting |
|||
Phase: |
1/2 |
Start Date 10/01/2014 |
Age of Trial (yrs) 9.6 |
|
Treatment Phase: |
First-line |
|||
Drug Category: |
KIT and FGFR inhiitor |
|||
Strategy: |
Block KIT & Block FGFR |
|||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
14-140 |
|||
Sponsor: |
Memorial Sloan-Kettering Cancer Center |
|||
Patient Contact: |
William Tap, MD 646-888-4163
Ping Chi, MD, PhD 646-888-4166
|
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
1275 York Ave |
New York |
NY |
10065 |
USA |
|
Basking Ridge |
NJ |
USA |
|||
Commack |
NY |
11725 |
USA |
||
Rockvile Centre |
NY |
USA |
|||
Sleepy Hollow |
NY |
10591 |
USA |